Skip to content

Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats

Karolina Noworyta, Katarzyna Kamińska, Grzegorz Kreiner, Zofia Rogóż, Krystyna Gołembiowska

Neurotoxicity Research July 26, 2016 DOI: 10.1007/s12640-016-9654-0 via OpenAlex

Summary

AI-generated from the abstract

The hallucinogen 5-MeO-DIPT ('foxy') increases dopamine, serotonin, and glutamate release in rat brain regions including the striatum, nucleus accumbens, and frontal cortex, with varying potency. It raises serotonin and lowers its metabolite 5-HIAA in tissue, likely by inhibiting the serotonin transporter. Decreases in dopamine and its metabolites suggest possible damage to dopamine terminals or adaptive changes in turnover. DNA strand breaks persisted for up to 60 days, indicating marked neurotoxicity. The drug also induced head-twitch responses and potentiated forepaw treading, suggesting its hallucinogenic effects involve stimulation of 5-HT2A and 5-HT1A receptors.

Study at a glance

Characteristics Experimental study Peer reviewed
Population Freely moving rats
Intervention 5-MeO-DIPT
Dose 5, 10, and 20 mg/kg
Duration Up to 60 days after treatment
Topics Serotonin
Keywords Chemistry Tryptamine Dopamine Pharmacology
Citations 26
Key finding 5-MeO-DIPT increases extracellular dopamine, serotonin, and glutamate in rat brain regions, causes persistent DNA damage indicating neurotoxicity, and its hallucinogenic activity appears mediated by 5-HT2A and 5-HT1A receptors.

Abstract

5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT, 'foxy') is one of the most popular tryptamine hallucinogens in the illicit drug market. It produces serious adverse effects, but its pharmacological profile is not well recognized. In vitro data have shown that 5-MeO-DIPT acts as a potent serotonin transporter (SERT) inhibitor and displays high affinity at serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors. In this study, using microdialysis in freely moving rats, we examined the effect of 5-MeO-DIPT on dopamine (DA), serotonin (5-HT), and glutamate release in the rat striatum, nucleus accumbens, and frontal cortex. In search of a possible neurotoxic effect of 5-MeO-DIPT, we measured DA and 5-HT tissue content in the above rat brain regions and also determined the oxidative DNA damage with the comet assay. Moreover, we tested drug-elicited head-twitch response and a forepaw treading induced by 8-OH-DPAT. 5-MeO-DIPT at doses of 5, 10, and 20 mg/kg increased extracellular DA, 5-HT, and glutamate level but the differences in the potency were found between brain regions. 5-MeO-DIPT increased 5-HT and decreased 5-HIAA tissue content which seems to result from SERT inhibition. On the other hand, a decrease in DA, DOPAC, and HVA tissue contents suggests possible adaptive changes in DA turnover or damage of DA terminals by 5-MeO-DIPT. DNA single and double-strand breaks persisted up to 60 days after the treatment, indicating marked neurotoxicity of 5-MeO-DIPT. The induction of head-twitch response and potentiation of forepaw treading induced by 8-OH-DPAT indicate that hallucinogenic activity seems to be mediated through the stimulation of 5-HT2A and 5-HT1A receptors by 5-MeO-DIPT.

Explore topics

Comments

No comments yet.

Log in to comment